The severity of the recent pandemic and the absence of any specific medication impelled the
identification of existing drugs with potential in the treatment of Coronavirus disease-2019 …

Abstract Coronavirus disease 2019 (COVID‐19) outbreak is an ongoing pandemic caused
by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with considerable …

Coronavirus disease 2019 (COVID-19) is an infectious disease that rapidly spread
throughout the world leading to high mortality rates. Despite the knowledge of previous …

In late December 2019, the outbreak of respiratory illness emerged in Wuhan, China, and
spreads worldwide. World Health Organization (WHO) named this disease severe acute …

Abstract Coronavirus disease-19 (COVID-19), a devastating respiratory illness caused by
SARS-associated coronavirus-2 (SARS-CoV-2), has already affected over 64 million people …

Despite the ongoing vaccination efforts, there is still an urgent need for safe and effective
treatments to help curb the debilitating effects of COVID-19 disease. This systematic review …

Background: Coronavirus disease-2019 (COVID-19) has a wide range of pathophysiological
effects. Curcumin, an active constituent of Curcuma longa (turmeric), has several properties …

Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2) is the causative
agent of the coronavirus disease 2019 (COVID-19). The availability of effective and well …

Curcumin is proposed as a potential treatment option for coronavirus disease‐19 (COVID‐
19) by inhibiting the virus entrance, encapsulation and replication, and modulating various …

The main aim of the current study was to summarize the findings of available clinical studies
to assess nano‐curcumin's influence on COVID patients. A comprehensive online search …